These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 1786517)
1. The antimigraine drugs ergotamine and dihydroergotamine are potent 5-HT1C receptor agonists in piglet choroid plexus. Brown AM; Patch TL; Kaumann AJ Br J Pharmacol; 1991 Sep; 104(1):45-8. PubMed ID: 1786517 [TBL] [Abstract][Full Text] [Related]
2. Endothelial 5-HT receptors mediate relaxation of porcine pulmonary arteries in response to ergotamine and dihydroergotamine. Glusa E; Roos A Br J Pharmacol; 1996 Sep; 119(2):330-4. PubMed ID: 8886417 [TBL] [Abstract][Full Text] [Related]
3. Competitive antagonism by recognized 5-HT2 receptor antagonists at 5-HT1C receptors in pig choroid plexus. Sahin-Erdemli I; Schoeffter P; Hoyer D Naunyn Schmiedebergs Arch Pharmacol; 1991 Aug; 344(2):137-42. PubMed ID: 1944609 [TBL] [Abstract][Full Text] [Related]
4. 5-HT1C receptor-mediated stimulation of inositol phosphate production in pig choroid plexus. A pharmacological characterization. Hoyer D; Waeber C; Schoeffter P; Palacios JM; Dravid A Naunyn Schmiedebergs Arch Pharmacol; 1989 Mar; 339(3):252-8. PubMed ID: 2725702 [TBL] [Abstract][Full Text] [Related]
5. Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors. Villalón CM; De Vries P; Rabelo G; Centurión D; Sánchez-López A; Saxena P Br J Pharmacol; 1999 Feb; 126(3):585-94. PubMed ID: 10188968 [TBL] [Abstract][Full Text] [Related]
6. Modulation of 5-HT1C receptors and phosphoinositide system by ethanol consumption in rat brain and choroid plexus. Pandey SC; Dubey MP; Piano MR; Schwertz DW; Davis JM; Pandey GN Eur J Pharmacol; 1993 Sep; 247(1):81-8. PubMed ID: 8258364 [TBL] [Abstract][Full Text] [Related]
7. Serotonin agonists increase transferrin levels via activation of 5-HT1C receptors in choroid plexus epithelium. Esterle TM; Sanders-Bush E J Neurosci; 1992 Dec; 12(12):4775-82. PubMed ID: 1334504 [TBL] [Abstract][Full Text] [Related]
8. Identification of spinal 5-HT1C binding sites in the rat: characterization of [3H]mesulergine binding. Pranzatelli MR; Murthy JN; Pluchino RS J Pharmacol Exp Ther; 1992 Apr; 261(1):161-5. PubMed ID: 1560361 [TBL] [Abstract][Full Text] [Related]
9. Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs. Newton RA; Phipps SL; Flanigan TP; Newberry NR; Carey JE; Kumar C; McDonald B; Chen C; Elliott JM J Neurochem; 1996 Dec; 67(6):2521-31. PubMed ID: 8931486 [TBL] [Abstract][Full Text] [Related]
10. 5-HT1C receptor-mediated phosphoinositide hydrolysis in the rat choroid plexus after chronic treatment with clozapine. Kuoppamäki M; Pälvimäki EP; Syvälahti E; Hietala J Eur J Pharmacol; 1994 Apr; 255(1-3):91-7. PubMed ID: 8026557 [TBL] [Abstract][Full Text] [Related]
11. The pharmacology of ergotamine and dihydroergotamine. Silberstein SD Headache; 1997; 37 Suppl 1():S15-25. PubMed ID: 9009470 [TBL] [Abstract][Full Text] [Related]
12. Agonist actions of dihydroergotamine at 5-HT2B and 5-HT2C receptors and their possible relevance to antimigraine efficacy. Schaerlinger B; Hickel P; Etienne N; Guesnier L; Maroteaux L Br J Pharmacol; 2003 Sep; 140(2):277-84. PubMed ID: 12970106 [TBL] [Abstract][Full Text] [Related]
13. Effects of ergotamine and dihydroergotamine on 5-hydroxytryptamine-2A receptors in the isolated rat aorta. Kalkman HO; Schneider F Pharmacology; 1996 Dec; 53(6):351-5. PubMed ID: 9032799 [TBL] [Abstract][Full Text] [Related]
14. 5-HT1C receptors mediate phosphoinositide turnover activation in the immature rat hippocampus. Claustre Y; Eudeline B; Benavides J; Scatton B Eur J Pharmacol; 1992 Jan; 225(1):37-41. PubMed ID: 1311687 [TBL] [Abstract][Full Text] [Related]
16. 5-HT-induced transferrin production by choroid plexus epithelial cells in culture: role of 5-HT1c receptor. Tsutsumi M; Sanders-Bush E J Pharmacol Exp Ther; 1990 Jul; 254(1):253-7. PubMed ID: 2164094 [TBL] [Abstract][Full Text] [Related]
17. Interaction of arylpiperazines with 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors: do discriminatory 5-HT1B receptor ligands exist? Schoeffter P; Hoyer D Naunyn Schmiedebergs Arch Pharmacol; 1989 Jun; 339(6):675-83. PubMed ID: 2770889 [TBL] [Abstract][Full Text] [Related]
18. Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393. Briggs CA; Pollock NJ; Frail DE; Paxson CL; Rakowski RF; Kang CH; Kebabian JW Br J Pharmacol; 1991 Dec; 104(4):1038-44. PubMed ID: 1687364 [TBL] [Abstract][Full Text] [Related]
19. Ergotamine and dihydroergotamine: history, pharmacology, and efficacy. Silberstein SD; McCrory DC Headache; 2003 Feb; 43(2):144-66. PubMed ID: 12558771 [TBL] [Abstract][Full Text] [Related]
20. The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. Pazos A; Hoyer D; Palacios JM Eur J Pharmacol; 1984 Nov; 106(3):539-46. PubMed ID: 6519175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]